BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37021926)

  • 21. Presacral malignant teratoid neoplasm in association with pathogenic DICER1 variation.
    Nakano Y; Hasegawa D; Stewart DR; Schultz KAP; Harris AK; Hirato J; Uemura S; Tamura A; Saito A; Kawamura A; Yoshida M; Yamasaki K; Yamashita S; Ushijima T; Kosaka Y; Ichimura K; Dehner LP; Hill DA
    Mod Pathol; 2019 Dec; 32(12):1744-1750. PubMed ID: 31296931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management.
    McGee RB; Oak N; Harrison L; Xu K; Nuccio R; Blake AK; Mostafavi R; Lewis S; Taylor LM; Kubal M; Ouma A; Hines-Dowell SJ; Cheng C; Furtado LV; Nichols KE
    Clin Cancer Res; 2023 Apr; 29(7):1243-1251. PubMed ID: 36693186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline mutations in pediatric cancer cohort with mixed-ancestry Mexicans.
    Alonso-Luna O; Mercado-Celis GE; Melendez-Zajgla J; Barquera R; Zapata-Tarres M; Juárez-Villegas LE; Mendoza-Caamal EC; Rey-Helo E; Borges-Yañez SA
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2332. PubMed ID: 38093606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematologic indices in individuals with pathogenic germline DICER1 variants.
    Vasta LM; Khan NE; Higgs CP; Harney LA; Carr AG; Harris AK; Schultz KAP; McMaster ML; Stewart DR
    Blood Adv; 2021 Jan; 5(1):216-223. PubMed ID: 33570641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma.
    Seki M; Yoshida K; Shiraishi Y; Shimamura T; Sato Y; Nishimura R; Okuno Y; Chiba K; Tanaka H; Kato K; Kato M; Hanada R; Nomura Y; Park MJ; Ishida T; Oka A; Igarashi T; Miyano S; Hayashi Y; Ogawa S; Takita J
    Cancer Res; 2014 May; 74(10):2742-9. PubMed ID: 24675358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.
    Nichols KE; Heath JA; Friedman D; Biegel JA; Ganguly A; Mauch P; Diller L
    J Clin Oncol; 2003 Dec; 21(24):4505-9. PubMed ID: 14673037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1.
    Merideth MA; Harney LA; Vyas N; Bachi A; Carr AG; Hill DA; Dehner LP; Schultz KAP; Stewart DR; Stratton P
    Gynecol Oncol; 2020 Mar; 156(3):647-653. PubMed ID: 31952842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of pathogenic/likely pathogenic germline variants in cancer-related genes among children with acute leukemia in Saudi Arabia.
    Alsultan A; Essa M; Aljefri A; Ayas M; Alharbi M; Alkhayat N; Al-Anzi F; Yassin F; Alkasim F; Alharbi Q; Abdullah S; Jastaniah W
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28340. PubMed ID: 32359129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline mutations of DICER1 in Chinese women with BRCA1/BRCA2-negative familial breast cancer.
    Cao WM; Gao Y; Yang HJ; Xie SN; Meng XL; Pan ZW; Chen ZH; Huang J; Ye WW; Shao XY; Wang XJ
    Genet Mol Res; 2014 Dec; 13(4):10754-60. PubMed ID: 25526195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subsequent neoplasms in childhood cancer survivors.
    Zichová A; Eckschlager T; Ganevová M; Malinová B; Lukš A; Kruseová J
    Cancer Epidemiol; 2020 Oct; 68():101779. PubMed ID: 32682319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural renal abnormalities in the DICER1 syndrome: a family-based cohort study.
    Khan NE; Ling A; Raske ME; Harney LA; Carr AG; Field A; Harris AK; Williams GM; Dehner LP; Messinger YH; Hill DA; Schultz KAP; Stewart DR
    Pediatr Nephrol; 2018 Dec; 33(12):2281-2288. PubMed ID: 30178239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.
    Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A
    Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
    Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
    J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma.
    Wasserman JD; Sabbaghian N; Fahiminiya S; Chami R; Mete O; Acker M; Wu MK; Shlien A; de Kock L; Foulkes WD
    J Clin Endocrinol Metab; 2018 May; 103(5):2009-2015. PubMed ID: 29474644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors.
    Yavvari S; Makena Y; Sukhavasi S; Makena MR
    Children (Basel); 2019 Nov; 6(12):. PubMed ID: 31795500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second malignant neoplasm following childhood cancer: A nested case-control study of a recent cohort (1987-2004) from the Childhood Cancer Registry of the Rhône-Alpes region in France.
    Casagranda L; Oriol M; Freycon F; Frappaz D; Bertrand Y; Bergeron C; Plantaz D; Stephan JL; Freycon C; Gomez F; Berger C; Trombert-Paviot B
    Pediatr Hematol Oncol; 2016 Sep; 33(6):371-382. PubMed ID: 27687523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ten years of DICER1 mutations: Provenance, distribution, and associated phenotypes.
    de Kock L; Wu MK; Foulkes WD
    Hum Mutat; 2019 Nov; 40(11):1939-1953. PubMed ID: 31342592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
    Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
    Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germ-line and somatic DICER1 mutations in pineoblastoma.
    de Kock L; Sabbaghian N; Druker H; Weber E; Hamel N; Miller S; Choong CS; Gottardo NG; Kees UR; Rednam SP; van Hest LP; Jongmans MC; Jhangiani S; Lupski JR; Zacharin M; Bouron-Dal Soglio D; Huang A; Priest JR; Perry A; Mueller S; Albrecht S; Malkin D; Grundy RG; Foulkes WD
    Acta Neuropathol; 2014 Oct; 128(4):583-95. PubMed ID: 25022261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.
    Khan NE; Bauer AJ; Schultz KAP; Doros L; Decastro RM; Ling A; Lodish MB; Harney LA; Kase RG; Carr AG; Rossi CT; Field A; Harris AK; Williams GM; Dehner LP; Messinger YH; Hill DA; Stewart DR
    J Clin Endocrinol Metab; 2017 May; 102(5):1614-1622. PubMed ID: 28323992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.